Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae

Mise à jour : Il y a 4 ans
Référence : NCT00729313

Femme et Homme

Extrait

The purpose of the protocol, is to determine whether lanreotide 30 mg is effective in the treatment of patients with digestive fistulae.


Critère d'inclusion

  • Digestive Fistulae

Liens